8 Analysts Have This to Say About Roivant Sciences
Portfolio Pulse from Benzinga Insights
Roivant Sciences (NASDAQ:ROIV) received 8 analyst ratings in the last quarter, with 3 bullish, 5 somewhat bullish, and none bearish. The average 12-month price target for ROIV is $16.38, with a high of $23.00 and a low of $15.00. This target has increased by 9.2% over the past month.
November 14, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Roivant Sciences has received mostly bullish ratings from analysts, with an average price target of $16.38, which has seen a 9.2% increase over the past month.
The predominantly bullish ratings and the recent increase in the average price target suggest a positive outlook for ROIV, which could lead to a short-term increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100